miltefosine has been researched along with Multiple Myeloma in 3 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, J | 1 |
| Seupel, R | 1 |
| Feineis, D | 1 |
| Mudogo, V | 1 |
| Kaiser, M | 1 |
| Brun, R | 1 |
| Brünnert, D | 1 |
| Chatterjee, M | 1 |
| Seo, EJ | 1 |
| Efferth, T | 1 |
| Bringmann, G | 1 |
| Camilleri, M | 1 |
| Richards, H | 1 |
| Pomplun, S | 1 |
| Wilson, A | 1 |
| Checkley, A | 1 |
| Rabin, N | 1 |
| Viseux, V | 1 |
| Schoenlaub, P | 1 |
| Danhier, S | 1 |
| Vilque, JP | 1 |
| Plantin, P | 1 |
3 other studies available for miltefosine and Multiple Myeloma
| Article | Year |
|---|---|
Dioncophyllines C
Topics: Alkaloids; Antimalarials; Antineoplastic Agents; Humans; Isoquinolines; Magnoliopsida; Molecular Str | 2017 |
Leishmaniasis as an unusual cause of pancytopenia in a patient receiving immunomodulatory therapy for myeloma.
Topics: Aged; Antiprotozoal Agents; Combined Modality Therapy; Drug Substitution; Endemic Diseases; Humans; | 2020 |
[Multiple cutaneous plasmocytoma treated with topical applications of miltefosine].
Topics: Administration, Topical; Aged; Antineoplastic Agents; Female; Humans; Multiple Myeloma; Phosphorylch | 2004 |